Tosun, MustafaKaragoz, Yalcin2024-08-232024-08-2320222459-1459https://doi.org/10.33808/clinexphealthsci.978423https://hdl.handle.net/20.500.12684/13835Objective: Rosacea-Specific Quality of Life Scale (RosaQoL) developed specifically for rosacea. The aim of the study was to adapt the RosaQoL Scale that is specific to Rosacea used in evaluating the quality of life of patients with Rosacea into Turkish, and evaluate its validity and reliability. Methods: The RosaQoL Scale is a 21-item index that is specific to Rosacea, and was developed originally in English. The Turkish Scale, which was created after the clinical examinations of the patients, was applied to the patients. A total of 285 people, 240 females (84.2%) and 45 males (15.8%), who were diagnosed with Rosacea, admitting to the dermatology clinic between May 2019 and August 2019 were included in the study. Results: The mean age of the patients was found to be 44.8 +/- 12.5 years in the study. The internal consistency of the scale (Cronbach's Alpha Coefficient) was found to be 0.952. The correlation coefficient was calculated as r=0.988 in the test-retest reliability. The total RosaQoL score was 62.4 +/- 11.5 (Mean +/- SD), and the total DLQI score was 7.85 +/- 5.04 (Mean +/- SD). For validity analysis, the correlation coefficient between RosaQoL and DLQI was calculated as r=0.411 (p<0.05). Conclusion: The Turkish version of the RosaQoL was valid and reliable for evaluating the quality of life of Turkish Rosacea patients.en10.33808/clinexphealthsci.978423info:eu-repo/semantics/openAccessQuality of LifeTurkish versionValidationReliabilityRosaceaQuestionnaireArticle1249991004WOS:000972204100028N/A